NCT00240526View on ClinicalTrials.gov

LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Engerix™ -B

3 (Groups A and C) or 4 (Groups B and D) intramuscular injections during the primary study

BIOLOGICAL

Hepatitis B immunoglobulin (HBIg)

1 intramuscular injections at birth (primary study)

Trial Locations (1)

10330

GSK Investigational Site, Bangkok

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY